Results 21 to 30 of about 102,651 (313)
In patients diagnosed with chronic kidney disease (CKD), atrial fibrillation (AF) is associated with an increased risk of thromboembolism and stroke. Moreover, patients with CKD — especially those in end-stage renal disease — also present an increased ...
Justyna Domienik-Karłowicz +4 more
doaj +1 more source
The Prophylaxis of Venous Thromboembolism [PDF]
Venous thromboembolism (VTE) is the third most common cardiovascular condition, after myocardial infarction and stroke. Prophylactic measures in accordance with current guidelines can significantly reduce the risk of VTE and the associated morbidity and mortality.
Albrecht, Encke, Sylvia, Haas, Ina, Kopp
openaire +2 more sources
Knowledge, Awareness and Risk of Occurrence of Venous Thromboembolism of Perinatal Women [PDF]
PURPOSE: The purpose of this study is to identify knowledge, awareness, and risk of occurrence of venous thromboembolism among pregnant women. METHODS: Subjects were 106 pregnant women treated as inpatients and outpatients at a women's health ...
Eun Sook Kim, Hye Young Kim
doaj +1 more source
Background Approximately a decade has passed since the addition of venous thromboembolism to the list of significant adverse reactions of antipsychotic drugs.
Hiroyuki Hashimoto +4 more
doaj +1 more source
Cancer and thrombosis: Managing the risks and approaches to thromboprophylaxis [PDF]
Patients with cancer are at increased risk of venous thromboembolism (VTE) compared with patients without cancer. This results from both the prothrombotic effects of the cancer itself and iatrogenic factors, such as chemotherapy, radiotherapy, indwelling
Erhard Hiller, Hiller, Erhard
core +1 more source
Venous thromboembolism (VTE) has been a subject of great interest of late. Since Rudolph Virchow described the famous Virchow's triad in 1856, there have been rapid strides in the understanding of the pathogenesis and factors responsible for it. Discovery of various thrombophilic factors, both primary and acquired, in the last
Dutta, T.K., Venugopal, V.
openaire +4 more sources
Omalizumab as a Provoking Factor for Venous Thromboembolism
A 43-year-old man with a history of severe extrinsic allergic asthma treated with once-monthly omalizumab (600 mg) for the last 15 months. He presented to the emergency room with a 2-week history of right lower limb pain and chest pleuritic pain ...
Crhistian-Mario Oblitas +4 more
doaj +1 more source
Introduction: Genetic risk factors that increase venous thromboembolism risk are disorders in the synthesis or activity of coagulation factors. Factor V Leiden, prothrombin (20210-A), antithrombin deficiency, protein C and protein S deficiency, and ...
Marjan Nove Baloski +9 more
doaj +1 more source
Background: Venous thromboembolism is a preventable cause of morbidity and mortality after surgery. To ensure that patients receive appropriate venous thromboembolism chemoprophylaxis, a nonmandatory risk-stratification tool based on patient clinical ...
Radhika Rastogi, MD +5 more
doaj +1 more source
Effect of statins on venous thromboembolic events: a meta-analysis of published and unpublished evidence from randomised controlled trials [PDF]
Background - It has been suggested that statins substantially reduce the risk of venous thromboembolic events. We sought to test this hypothesis by performing a meta-analysis of both published and unpublished results from randomised trials of statins.
Jacquet Hervet, Michel +134 more
core +1 more source

